Biomarin Pharmaceutical Inc (BMRN)
66.60
+0.71
(+1.08%)
USD |
NASDAQ |
Nov 01, 16:00
66.60
0.00 (0.00%)
After-Hours: 20:00
Biomarin Pharmaceutical Shareholders Equity (Quarterly): 5.413B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.413B |
| June 30, 2024 | 5.286B |
| March 31, 2024 | 5.074B |
| December 31, 2023 | 4.952B |
| September 30, 2023 | 4.897B |
| June 30, 2023 | 4.783B |
| March 31, 2023 | 4.659B |
| December 31, 2022 | 4.603B |
| September 30, 2022 | 4.569B |
| June 30, 2022 | 4.505B |
| March 31, 2022 | 4.391B |
| December 31, 2021 | 4.266B |
| September 30, 2021 | 4.266B |
| June 30, 2021 | 4.242B |
| March 31, 2021 | 4.162B |
| December 31, 2020 | 4.106B |
| September 30, 2020 | 4.054B |
| June 30, 2020 | 3.237B |
| March 31, 2020 | 3.240B |
| December 31, 2019 | 3.122B |
| September 30, 2019 | 3.074B |
| June 30, 2019 | 2.961B |
| March 31, 2019 | 2.937B |
| December 31, 2018 | 2.968B |
| September 30, 2018 | 2.915B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.885B |
| March 31, 2018 | 2.807B |
| December 31, 2017 | 2.809B |
| September 30, 2017 | 2.814B |
| June 30, 2017 | 2.796B |
| March 31, 2017 | 2.769B |
| December 31, 2016 | 2.766B |
| September 30, 2016 | 2.646B |
| June 30, 2016 | 1.918B |
| March 31, 2016 | 2.290B |
| December 31, 2015 | 2.401B |
| September 30, 2015 | 2.293B |
| June 30, 2015 | 2.357B |
| March 31, 2015 | 2.425B |
| December 31, 2014 | 1.528B |
| September 30, 2014 | 1.508B |
| June 30, 2014 | 1.462B |
| March 31, 2014 | 1.460B |
| December 31, 2013 | 1.341B |
| September 30, 2013 | 1.276B |
| June 30, 2013 | 1.258B |
| March 31, 2013 | 1.250B |
| December 31, 2012 | 1.016B |
| September 30, 2012 | 1.015B |
| June 30, 2012 | 1.000B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.122B
Minimum
Dec 2019
5.413B
Maximum
Sep 2024
4.391B
Average
4.448B
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 43.58B |
| Bristol-Myers Squibb Co | 17.14B |
| Alnylam Pharmaceuticals Inc | 32.35M |
| Bioventus Inc | 150.94M |
| Moderna Inc | 11.71B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.851B |
| Total Liabilities (Quarterly) | 1.438B |
| Debt to Equity Ratio | 0.1098 |
| Current Ratio | 4.271 |
| Net Debt Paydown Yield | 0.73% |